Position in PRGO
as of Jun 30, 2026
· filed Aug 10, 2026
Position Value
$478,729
-$51,182 QoQ
Shares Held
46,076
-6.6% QoQ
Ownership
0.033%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#130
of 334 holders
Holding Since
Mar 2021
18 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PRGO Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026PHILADELPHIA TRUST CO holds $10,531,842 across 4 Drug Manufacturers - Specialty & Generic names. PRGO ranks #3 (4.5% of the industry book) .
All Filings in PRGO
Export CSV
18 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $478,729 | 46,076 | Shares | Sole | 2026-08-10 | |
| 2026-03-31 | $529,911 | 49,340 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $697,517 | 50,109 | Shares | Sole | 2026-02-12 | |
| 2025-09-30 | $1,336,222 | 60,001 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $1,603,226 | 60,001 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $1,845,368 | 65,812 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $1,809,084 | 70,365 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $1,970,712 | 75,132 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $1,938,223 | 75,476 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $2,696,363 | 83,764 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $2,853,336 | 88,668 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $2,525,711 | 79,052 | Shares | Sole | 2023-11-09 | |
| 2023-06-30 | $2,757,622 | 81,226 | Shares | Sole | 2023-08-07 | |
| 2023-03-31 | $2,972,977 | 82,882 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $2,860,048 | 83,897 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $3,177,020 | 89,092 | Shares | Sole | 2022-11-10 | |
| 2021-06-30 | $2,043,076 | 44,560 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $1,742,638 | 43,060 | Shares | Sole | 2021-05-14 | |
| No filing history on record for this holder in this stock. | ||||||